Lab/ECG/Xray Rounds The EM Resident Provisionally Known as Sean Caine CCFP-EM March 5, 2008.

Slides:



Advertisements
Similar presentations
LQTS Outline Background Identification Therapies Available
Advertisements

Cardiac Issues in Athletic Participation: To Screen or Not to Screen?
Kulić M., Mujičić E., Šošević A., Gorani D.*, Tahirović E., Spužić M.
Management of the Patient Presenting with Wide Complex Tachycardia
Kate Thomson Molecular Genetics Laboratory, Oxford
Aortic Stenosis Amit J. Thosani 10 September 2008.
“ Now that we have his genes, can my child wear soccer shorts?” Janet N Scheel, MD Pediatric Cardiology.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Syncope in Children.
Brugada’s Syndrome and Sudden Cardiac Death
Hypertrophic Cardiomyopathy
Cardiovascular Disaster in Hemodialysis patients
Case Rounds Laura Miles Teams Case Rounds February
Cardiac Pathology in Athletes. Sudden Death About 25 young patients die each year nationally in sudden-initially unexplained deaths on the field in all.
DOMENICO CORRADO, MD, PhD University of Padova, Italy
W. Kissinger Tintinalli Sixth Edition Chapter 52
Hypertrophic Cardiomyopathy Guidelines Summary from the: ACC/ESC Clinical Expert Consensus Statement on Hypertrophic Cardiomyopathy Maron BJ, et al. J.
Brugada Syndrome Carly Thompson MD CCFP EM Resident July 31, 2008.
Thursday 4/12/2014 Hassan Alahmadi Medical Resident ( R1)
A case of inappropriate ICD shock causing cardiac arrest
1. Etiology of Hypertrophic Cardiomyopathy is mostly due to: A. Long-term Hypertension B. Aortic Stenosis C. Myocardial Ischemia D. Familial and Genetic.
Cardiomyopathies Dr. Hesham K. Rashid, MD Ass. Professor of Cardiology Benha University.
Primary Myocardial Disease Dr. Raid Jastania. Case.
 Genetic disease of heart muscle characterized by left ventricular hypertrophy in absence of another cardiac or systemic disease; variable morphologies.
Dr. Meg-angela Christi M. Amores
Heart disease. Congenital Ischemic Hypertensive Valvular Cardiomyopathy Pericardium Tumors.
Hypertrophic Cardiomyopathy
Understanding Cardiomyopathy
CPC Hypertrophic Cardiomyopathy. FACTS of INTEREST Patient was relatively asymptomatic until follow-up visit at WRAMC. Both his mother and older sibling.
Prof. N. Sudhaya Kumar, AIMS, Cochin. Primary cardiomyopathies Genetic HCM ARVD LV noncompaction Mitochondral myopathy Glyc.storage dis. channelopathies.
Heart Conditions. Acute Chest pain Crushing pain Cardiac pain patterns Pain referred to left jaw, shoulder, arm Syncope Excessive sweating Pale skin Difficulty.
Dr Kok Lai Sun Department of Medicine Hospital Pulau Pinang
The Electrical Management of Cardiac Rhythm Disorders Tachycardia Indications for ICD Implantation.
Valvular Heart Disease
1 Nora Goldschlager, M.D. Cardiology – San Francisco General Hospital UCSF Disclosures: None ECG MIMICS OF MYOCARDIAL ISCHEMIA AND INFARCTION.
Wellens Syndrome Abel David. Wellens Syndrome is a pattern in anterior leads, V2 and V3 Deeply inverted or biphasic T-waves Highly specific for critical.
 R40: 30 yo man found unconscious, on ambo arrival VT. ROSC after single DC shock  In ED conscious, mildly intoxicated  Normal bloods, CXR, alcohol.
Genetics & Heart Disease Donald Ferrari, DO,FACC Main Line Healthcare Cardiology in Lionville Candace S. Peterson, MS, CGC Certified Genetic Counselor.
Date of download: 5/31/2016 Copyright © The American College of Cardiology. All rights reserved. From: Spectrum and prognostic significance of arrhythmias.
IN THE NAME OFGODIN THE NAME OFGOD SVTS.SAYAH.  All cardiac tachyarrhythmias are produced by: 1/disorders of impulse initiation :automatic 2/abnormalities.
THE HEART’S ELECTRICAL SYSTEM Marco Perez, MD Center for Inherited Cardiovascular Disease Inherited Cardiac Arrhythmia Clinic June 20, 2013.
Palpitations and Common Arrhythmias J. Philip Saul, M.D. West Virginia University Morgantown, WV.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Cardiomyopathies Pavol Tomašov.
Syncope UCI Internal Medicine Core Curriculum - Mini Lecture
Sudden Cardiac Arrest Morhaf Ibrahim, MD, FHRS Electrophysiology.
Disclosures None.
Risk Stratification of Chest Pain: Best Practices
Obstructive Hypertrophic Cardiomyopathy
Brugada’s Syndrome and Sudden Cardiac Death
Screening Outcomes and Long-term Data
Figure 1 Incidence and total numbers of SCD in patients with depressed LV systolic function and in patients with preserved LV function. The incidence of.
Takotsubo Cardiomyopathy (broken heart syndrome) Domina Petric, MD
Hypertrophic Cardiomyopathy
HYPERTROPHIC CARDIOMYOPATHY(HCM)
LVH & Heart murmur Murmur Increased w/ standing
Syncope in children.
Figure 6 Risk stratification in hypertrophic cardiomyopathy (HCM)
CARDIOMYOPATHY 101 Elaine M. Szewc, RN, BS
ECG rounds: The ECG in (pre)syncope
Sudden Cardiac Arrest in Intercollegiate Athletics
Volume 350, Issue 9087, (November 1997)
Slides courtesy of Dr. Randall Harada
Bar chart of systolic function in healthy individuals, HCM LVH− patients and HCM LVH+ patients. GLS was significantly worse in the HCM LVH+ patients compared.
Jeffrey B. Geske et al. JCHF 2018;j.jchf
Evaluating Success of Current Treatments for HCM
LVH & Heart murmur Murmur Increased w/ standing
Examples of association between CMR features and abnormal Q waves.
Screening for Sudden Cardiac Death in Athletes and Low-Risk Patients
Illustration of discordance between location of Q waves on ECG derivations and location of LGE in the myocardium on CMR. (A) Incidence of LGE within cited.
Presentation transcript:

Lab/ECG/Xray Rounds The EM Resident Provisionally Known as Sean Caine CCFP-EM March 5, 2008

Case 29 yo male presents with severe lightheadedness and palpitations during sexual activity Symptoms persisted x min Spontaneous resolution

Case continued Additional hx: 2 prev visits to ED in past month for similar symptoms 1 st episode Lightheaded while mowing the lawn D/C home from ED after ECG and normal labs 2nd episode Syncopal watching TV Admitted for observation Had serial cardiac enzymes and cardiac monitoring Discharged home after negative work up Instructed to f/u with GP

Case Normal vitals and physical exam ECG is obtained….

Hypertrophic Cardiomyopathy (HCM)

Objectives Background Background Etiology Etiology Pathophysiology Pathophysiology Clinical Presentation Clinical Presentation ECG Findings ECG Findings Treatment Treatment

Thank you… Adam Davidson and Jeff Booker

Background aka Idiopathic hypertrophic subaortic stenosis, obstructive cardiomyopathy aka Idiopathic hypertrophic subaortic stenosis, obstructive cardiomyopathy Notable cause of sudden cardiac death among athletes Notable cause of sudden cardiac death among athletes Accounting for 2-36% SCD among athletes Accounting for 2-36% SCD among athletes Prevalence of % of general population Prevalence of % of general population Accounts for up to 60% of unexplained LVH Accounts for up to 60% of unexplained LVH MOST COMMON genetic cardiovascular disorder MOST COMMON genetic cardiovascular disorder

Background SCD most common for those <35 yrs of age 1 SCD most common for those <35 yrs of age 1 –No age is immune from SCD Annual mortality rates as high as 3-6% 3 Annual mortality rates as high as 3-6% 3

Etiology 30-50% due to familial inheritance 1, % due to familial inheritance 1,5 Autosomal dominant inheritance with variable penetration Autosomal dominant inheritance with variable penetration mutations of 1 of 11 possible genes encoding proteins for myocardial sarcomere mutations of 1 of 11 possible genes encoding proteins for myocardial sarcomere

35% 15%

Pathophysiology Hypertrophied, nondilated left ventricle in the absence of another cause Hypertrophied, nondilated left ventricle in the absence of another cause Histology: Histology: –Hypertrophied muscle cells –Cellular disorganization in whorled pattern –Abnormal fibrous tissue –Scarring mimics healed MI

Schematic Asymmetric septal hypertrophy (ASH) Asymmetric septal hypertrophy (ASH) Systolic motion of MV anteriorleaflet (SAM) Systolic motion of MV anteriorleaflet (SAM) LVOT gradient LVOT gradient Mitral regurgitation (MR) Mitral regurgitation (MR)

2 Chamber Echo DiastoleSystole

Morphologic Variants of HCM

Clinical Presentation Can be completely asymptomatic Can be completely asymptomatic Presenting Symptoms Presenting Symptoms –Dyspnea –Exercise intolerance –Dizziness –Chest pain –Presyncope/syncope –Sudden Cardiac Death

Clinical Presentation Average age at diagnosis is yrs Average age at diagnosis is yrs 2% diagnosed before the age of 5 2% diagnosed before the age of 5 7% before the age of 10 7% before the age of 10

Key features on history Previous hx of syncope Family history of SCD or early onset of symptoms

Physical Examination S4 gallop S4 gallop Harsh crescendo-decrescendo midsystolic murmur loudest at apex Harsh crescendo-decrescendo midsystolic murmur loudest at apex – LOUDER with valsalva and standing –SOFTENS with lying, squatting, or isometric exercise Bifid arterial pulse,double/triple apical impulse,palpable atrial gallop Bifid arterial pulse,double/triple apical impulse,palpable atrial gallop

THE ECG Abnormal in 90% Abnormal in 90% ECG Findings LVH: 30% LVH: 30% – and associated ST and T wave changes Deep NARROW Q waves (typically I, aVL, V5, V6) Deep NARROW Q waves (typically I, aVL, V5, V6) Left atrial enlargement: 25-50% Left atrial enlargement: 25-50%

30 yo male with 20 min of lightheadedness running to bus

31 yo female syncope preceded by palpitations during physical activity

?????

Diagnosis Ultimately made by doppler Echo Ultimately made by doppler Echo

Complications Increased incidence of WPW Increased incidence of WPW Chronic or paroxysmal afib (10-40%) Chronic or paroxysmal afib (10-40%) Moderate risk for infective endocarditis Moderate risk for infective endocarditis SCD SCD

Pharmacotherapy β blockers are first line β blockers are first line –Verapamil or disopyramide prescribed with caution when β blocker poorly tolerated Afterload reducing agents with systolic dysfunction/CHF Afterload reducing agents with systolic dysfunction/CHF –ACEI, diuretics, digoxin Amiodarone should be used for ventricular dysrhythmias Amiodarone should be used for ventricular dysrhythmias Avoid nitrates (decrease preload and LVOT) Avoid nitrates (decrease preload and LVOT)

Nonpharmacologic therapy Septal myomectomy Septal myomectomy Alcohol septal ablation Alcohol septal ablation ICD ICD

Take Home Points Be suspicious of unexplained LVH on ECG Be suspicious of unexplained LVH on ECG –Especially in symptomatic patients Think HCM with narrow qwaves in lateral leads Think HCM with narrow qwaves in lateral leads

References Ramaraj R. Hypertrophic Cardiomyopathy: Etiology, Diagnosis, Treatment. Cardiology in Review. 2008; 14(4): Dovgalyuk J, Holstege C, Mattu A, Brady WJ. The electrocardiogram in the patient with syncope. American Journal of Emergency Medicine. 2007; 25: Kelly BS, Mattu A, Brady WJ. Hypertrophic cardiomyopathy: electrocardiographic manifestations and other important considerations for the emergency physician. American Journal of Emergency Medicine. 2007; 25: Jouriles NJ. Hypertrophic Cardiomyopathy. Marx: Rosens Emergency Medicine: Concepts and Clinical Practice. 6 th ed Niemann JT. Hypertrophic Cardiomyopathy. Emergency Medicine: A comprehensive study guide. 6th ed. 2004:

Sudden Cardiac Death Risk factors Risk factors Sustained VT Sustained VT Recurrent syncope (esp w/exertion) Recurrent syncope (esp w/exertion) Family hx of 1 or more SCD Family hx of 1 or more SCD Extreme LVH (>30mm wall thickness) Extreme LVH (>30mm wall thickness) LVOT gradient >30mmHg LVOT gradient >30mmHg Abnormal BP response to exercise Abnormal BP response to exercise Nonsustained VT ambulatory monitor Nonsustained VT ambulatory monitor 0-1 RF = 1% annual SCD rate 0-1 RF = 1% annual SCD rate 2 or more= increased risk of SCD and prophylactic ICD should be considered 2 or more= increased risk of SCD and prophylactic ICD should be considered

Distinguishing hypertrophic cardiomyopathy (HCM) from "Athlete's Heart" ParameterFindings in HCMFindings in Athlete's Heart LV wall thickness and morphology Can be >16 mm; can be heterogeneous or asymmetric across segments Typically <16 mm, especially in women; symmetric Diastolic LV cavity<45 mm (except in late, dilated phase)>55 mm LA sizeEnlargedNormal LV diastolic filling pattern Impaired relaxation (E:A ratio <1, prolonged diastolic deceleration time) Normal Response to deconditioning NoneLV wall thickness decreases EKG findings Very high QRS voltages; Q waves; deep negative T waves Criteria for LVH but without unusual features Family history of HCM Present (except de novo mutations)Absent LV: left ventricle; LA: left atrium; LVH: left ventricular hypertrophy. Adapted from Maron, BJ, Pellicia, A, Spirito, P. Circulation 1995; 91:1596.

25 yo male severe palpitations, lightheadedness, presyncope playing basketball